These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2243441)

  • 1. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
    Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
    Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
    Ewers SB; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Killander D
    Breast Cancer Res Treat; 1992; 24(2):115-26. PubMed ID: 8443399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.
    Ohyama S; Yonemura Y; Miyazaki I
    Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
    Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
    Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.
    Ewers SB; Attewell R; Baldetorp B; Borg A; Långström E; Killander D
    Breast Cancer Res Treat; 1992 Jan; 20(2):93-108. PubMed ID: 1554892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of ploidy and S-phase fraction in primary intraoral squamous cell carcinoma and their corresponding metastatic lymph nodes.
    El-Deftar MF; El Gerzawi SM; Abdel-Azim AA; Tohamy SM
    J Egypt Natl Canc Inst; 2012 Mar; 24(1):7-14. PubMed ID: 23587227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
    Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
    Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
    Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
    Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
    Prasad AR; Divine G; Zarbo RJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between DNA ploidy and survival in patients with primary breast cancer.
    Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
    Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
    Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
    J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.
    Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
    Int J Cancer; 1992 Apr; 51(1):28-33. PubMed ID: 1563841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
    Redkar AA; Balsara BR; Bhisey AN; Sampat MB; Mittra I
    Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.